Neurological Complications Associated with Particulate Steroid Use During Interlaminar ESI
- Registration Closed
Myth: Interlaminar epidural injection with particulate as opposed to non-particulate steroid poses a greater risk of thrombotic/embolic-related neurologic complications.
Each participant will read the FactFinder and will answer post-test questions to earn continuing medical education (CME) credits.
Authors
Clark C. Smith, MD, MPH: Shaan Sudhakaran, MD: and Zachary L. McCormick, MD on behalf of the Spine Intervention Society’s Patient Safety Committee
Copyright
Materials presented in this activity have been made available by the Spine Intervention Society for educational purposes only. We reserve all rights to such material.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Identify best practices to ensure patient safety during interventional spine procedures
- Cite the evidentiary basis for risk mitigation strategies in the safe performance of interventional pain procedures
Author Disclosure Information
RELEVANT FINANCIAL RELATIONSHIPS WITH ACCME DEFINED COMMERCIAL INTERESTS
Clark C. Smith, MD, MPH
Nothing to disclose
Shaan Sudhakaran, MD
Nothing to disclose
Zachary L. McCormick, MD
Nothing to disclose
OTHER DISCLOSURES
Clark C. Smith, MD, MPH
Nothing to disclose
Shaan Sudhakaran, MD
Nothing to disclose
Zachary L. McCormick, MD
Grant and research support: Foundation of PM&R, Midwest Pain Society, SIS
Position in physician society/associations: AAPM
References
References are provided within the FactFinder.
Accreditation Statement
The Spine Intervention Society (SIS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
SIS designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Date of Activity Release: 8/13/2020
Date of Activity Expiration: 8/12/2023